Figure 2.
The time to treatment failure (TTF) and overall survival (OS) in patients treated with each tyrosine kinase inhibitor. The values of TTF (A) and OS (B) were not significantly different between the treatment groups.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.